Healthcare & Pharmaceuticals

BioNTech CEO says likelihood of annual COVID-19 vaccines increasing

1 minute read

CEO and co-founder of BioNTech, Ugur Sahin attends a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi

FRANKFURT, Dec 3 (Reuters) - The likelihood that people will need to have an annual COVID-19 vaccine, similar to the influenza shot, is increasing, German company BioNTech (22UAy.DE), chief executive and co-founder Ugur Sahin told the Reuters Next conference on Friday.

To watch the Reuters Next conference please register here

Register now for FREE unlimited access to
Reporting by Ludwig Burger, Josephine Mason and Keith Weir; editing by John Stonestreet

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters